Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial

Judith Absalon, Nathan Segall, Stan L. Block, Ingrid L. Scully, Peter C. Giardina, James T. Peterson, Wendy J. Watson, William C. Gruber, Kathrin U. Jansen, Yahong Peng, Samantha Munson, Danka Pavliakova, Daniel A. Scott, Annaliesa S. Anderson